European Lithium (EUR) has announced the sale of an additional 3.03 million shares of Critical Metals Corp (CRML) to a US institutional investor, generating around $50m (A$76m) in net proceeds. This off-market transaction involved shares priced at $16.50 each. Furthermore, CRML has finalised a private placement, raising an equivalent amount of $50m in equity funding. The company has outlined its intention to use these funds to develop the Tanbreez Rare Earth Project in Greenland. According to the securities purchase agreement, CRML will issue 1.47 million ordinary shares at a price of $16.50 per share, accumulating to the total purchase price of $50m. In addition, pre-funded warrants have been issued, which will allow for the acquisition of around 1.56 million additional shares. The shares and warrants distributed in this private placement come with resale registration rights. EUR executive chairman Tony Sage said: “The capital raising undertaken by CRML demonstrates continued investor confidence in the US markets in CRML as they continue to advance the strategic portfolio of critical mineral assets. We are receiving a lot of enquiries from EUR shareholders regarding the discrepancy between the EUR market capitalisation against its shareholding in CRML. “EUR currently holds 53,036,338 shares in CRML and using the US$22.72 closing price on the Nasdaq on 16 October 2025, values the company’s holding at approximately US$1.2bn (A$1.85bn), which equates to A$1.23 per EUR share, which is well above the current market capitalisation of EUR despite recent increases in the EUR share price. "We are aware of this discrepancy and continue to execute a range of strategic options aimed at better reflecting this intrinsic value. The company now has over $190m in cash reserves.” Last year, EUR closed a business partnership with Sizzle Acquisition, resulting in the creation of Critical Metals. "European Lithium sells 3.03 million shares of CRML " was originally created and published by Mining Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. View Comments
European Lithium sells 3.03 million shares of CRML
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...